Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 175

1.

A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.

Shin DW, Chun S, Kim YI, Kim SJ, Kim JS, Chong S, Park YS, Song SY, Lee JH, Ahn HK, Kim EY, Yang SH, Lee MK, Cho DG, Jang TW, Son JW, Ryu JS, Cho MJ.

PLoS One. 2018 Feb 8;13(2):e0192626. doi: 10.1371/journal.pone.0192626. eCollection 2018.

2.

Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on <sup>18</sup> F-fluorodeoxyglucose positron emission tomography/computed tomography.

Takada K, Toyokawa G, Okamoto T, Baba S, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Honda H, Oda Y, Maehara Y.

Cancer Med. 2017 Nov;6(11):2552-2561. doi: 10.1002/cam4.1215. Epub 2017 Oct 4.

3.

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.

Zhao J, Dinkel J, Warth A, Penzel R, Reinmuth N, Schnabel P, Muley T, Meister M, Zabeck H, Steins M, Yang JY, Zhou Q, Schlemmer HP, Herth FJF, Kauczor HU, Heussel CP.

PLoS One. 2017 Sep 26;12(9):e0182741. doi: 10.1371/journal.pone.0182741. eCollection 2017.

4.

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.

Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, Duffy S, Field JK.

Thorax. 2017 Oct;72(10):912-918. doi: 10.1136/thoraxjnl-2016-209690. Epub 2017 Jul 14.

5.

ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.

Mamesaya N, Nakashima K, Naito T, Nakajima T, Endo M, Takahashi T.

BMC Cancer. 2017 Jul 6;17(1):471. doi: 10.1186/s12885-017-3468-1. Review.

6.

A qualitative analysis of smokers' perceptions about lung cancer screening.

Gressard L, DeGroff AS, Richards TB, Melillo S, Kish-Doto J, Heminger CL, Rohan EA, Allen KG.

BMC Public Health. 2017 Jun 21;17(1):589. doi: 10.1186/s12889-017-4496-0.

8.

A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.

Yeo J, Crawford EL, Zhang X, Khuder S, Chen T, Levin A, Blomquist TM, Willey JC.

BMC Cancer. 2017 May 2;17(1):301. doi: 10.1186/s12885-017-3287-4.

9.

Development of Allograft Cancer after Lung Transplantation: A Case Report.

Schwarz EI, Vrugt B, Huber LC, Murer C, Schuurmans MM, Inci I, Benden C.

Ann Thorac Cardiovasc Surg. 2017 Aug 20;23(4):196-199. doi: 10.5761/atcs.cr.16-00221. Epub 2017 Mar 29.

10.

Clinical and computed tomography findings in Chinese lung cancer patients with HIV infection: A multi-center study.

Cheng Z, Shan F, Liu J, Shi Y, Zhang Z, Wu G.

Thorac Cancer. 2017 May;8(3):238-245. doi: 10.1111/1759-7714.12429. Epub 2017 Mar 15.

11.

A rare presentation of myxofibrosarcoma as a Pancoast tumor: a case report.

Jevremovic V, Yousuf A, Hussain Z, Abboud A, Chedrawy EG.

J Med Case Rep. 2017 Mar 7;11(1):61. doi: 10.1186/s13256-017-1223-5.

12.

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.

Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, Spaggiari L, Bellomi M.

BMJ. 2017 Feb 8;356:j347. doi: 10.1136/bmj.j347.

13.

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

Ten Haaf K, Tammem├Ągi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF.

PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.

14.

Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.

Jeong E, Hyun SH, Moon SH, Cho YS, Kim BT, Lee KH.

Medicine (Baltimore). 2017 Feb;96(5):e5935. doi: 10.1097/MD.0000000000005935.

15.

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.

Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK.

Int J Cancer. 2017 Jun 1;140(11):2436-2443. doi: 10.1002/ijc.30602.

16.

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.

Cho J, Choi SM, Lee J, Lee CH, Lee SM, Yim JJ, Chung DH, Yoo CG, Kim YW, Han SK, Park YS.

PLoS One. 2016 Nov 18;11(11):e0166821. doi: 10.1371/journal.pone.0166821. eCollection 2016.

18.

The regional association between bronchiectasis and lung cancer in chest CT.

Kim YW, Lee CH, Jin KN, Lee JK, Heo EY, Park SS, Chung HS, Kim DK.

BMC Pulm Med. 2016 Nov 15;16(1):151.

19.

Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.

Kinsey CM, Hamlington KL, O'Toole J, Stapleton R, Bates JH.

PLoS One. 2016 Nov 2;11(11):e0165471. doi: 10.1371/journal.pone.0165471. eCollection 2016.

20.

Addition of the Fleischner Society Guidelines to Chest CT Examination Interpretive Reports Improves Adherence to Recommended Follow-up Care for Incidental Pulmonary Nodules.

McDonald JS, Koo CW, White D, Hartman TE, Bender CE, Sykes AG.

Acad Radiol. 2017 Mar;24(3):337-344. doi: 10.1016/j.acra.2016.08.026. Epub 2016 Oct 25.

Supplemental Content

Loading ...
Support Center